(AMED) Amundi Index Solutions - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU1602144575

European Stocks, Equity Funds, Large Cap Stocks

Description: AMED Amundi Index Solutions

Amundi Index Solutions - Amundi ETF MSCI EMU ESG Leaders Select (XETRA:AMED) is an ETF that tracks the Morningstar Developed Europe Zone TME NR EUR Index, focusing on Eurozone large-cap equities with a strong ESG (Environmental, Social, and Governance) profile.

The fund has a significant AUM of €1.217 billion, indicating a substantial investor base and liquidity. As an ESG-focused ETF, it is likely to appeal to investors prioritizing sustainability and responsible investing. The underlying index methodology likely incorporates ESG criteria to select constituents, potentially leading to a portfolio with a better ESG profile compared to a non-ESG filtered index.

From a trading perspective, AMED has shown a relatively stable price action, with a 52-week high of €328.60 and a low of €276.00. The current price is €320.15, near its SMA20 and SMA50, indicating a potential support level. The ATR of 0.82% suggests moderate volatility, which may be attractive to traders seeking to balance risk and potential returns.

To further evaluate AMED, key performance indicators (KPIs) such as tracking error, information ratio, and ESG metrics (e.g., carbon footprint, ESG score) could be analyzed. Additionally, comparing AMEDs performance and fees to similar ESG-focused Eurozone large-cap ETFs could provide insights into its relative attractiveness.

Investors should also consider the funds sector allocation, top holdings, and the overall ESG strategy to ensure alignment with their investment objectives and values. A thorough analysis of these factors will help determine whether AMED is a suitable addition to their portfolio.

Additional Sources for AMED ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

AMED ETF Overview

Market Cap in USD 1,423m
Category Eurozone Large-Cap Equity
TER 0.25%
IPO / Inception 2018-02-14

AMED ETF Ratings

Growth Rating 68.3
Fundamental -
Dividend Rating 0.0
Rel. Strength -4.4
Analysts -
Fair Price Momentum 307.05 EUR
Fair Price DCF -

AMED Dividends

Currently no dividends paid

AMED Growth Ratios

Growth Correlation 3m 48.8%
Growth Correlation 12m 72.4%
Growth Correlation 5y 86.8%
CAGR 5y 9.94%
CAGR/Max DD 5y 0.41
Sharpe Ratio 12m 1.29
Alpha -0.29
Beta 0.535
Volatility 11.01%
Current Volume 0.1k
Average Volume 20d 0.2k
Stop Loss 313.5 (-3.5%)
What is the price of AMED shares?
As of July 14, 2025, the stock is trading at EUR 324.85 with a total of 69 shares traded.
Over the past week, the price has changed by +0.59%, over one month by +1.55%, over three months by +11.00% and over the past year by +8.19%.
Is Amundi Index Solutions a good stock to buy?
Yes. Based on ValueRay's Analyses, Amundi Index Solutions (XETRA:AMED) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 68.30 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AMED is around 307.05 EUR . This means that AMED is currently overvalued and has a potential downside of -5.48%.
Is AMED a buy, sell or hold?
Amundi Index Solutions has no consensus analysts rating.
What are the forecasts for AMED share price target?
According to our own proprietary Forecast Model, AMED Amundi Index Solutions will be worth about 346 in July 2026. The stock is currently trading at 324.85. This means that the stock has a potential upside of +6.5%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 346 6.5%